Lipid biomarkers for newborn screening of treatable metabolic diseases: Discovery, assay Development, and implementation
Synopsis
Watch Recording
About Prof. Michael Gelb
Michael H. Gelb is Professor of Chemistry and Barbara L.
Weinstein Endowed Chair in Chemistry, Adjunct Professor of Biochemistry at the
University of Washington. Major developments in the Gelb lab include discovery
of protein prenylation, development of ICAT proteomic reagents, identification
of phospholipases involved in lipid mediator generation, development of
anti-parasite drugs, and development of mass spectrometry for newborn
screening. Awards include: Repligen Award in Chemistry of Biological Processes
(Amer. Chem. Soc.), Univ.of Washington Faculty Lecture Award, Gustavus John
Esselen Award (Harvard Univ.), AAAS Fellow, NIH Merit Award, Medicines for
Malaria Project of the Year Award, Pfizer Award in Enzyme Chemistry, ICI
Pharmaceuticals Award for Excellence in Chemistry. The Gelb lab has published
more than 500 papers and 100 patents in biological chemistry. The Gelb
laboratory has developed mass spectrometry for worldwide newborn screening of
lysosomal storage diseases (the latest expansion of newborn screening panels).